A Phase 2, Open-label Study of Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma
Phase of Trial: Phase II
Latest Information Update: 03 Aug 2018
At a glance
- Drugs Rucaparib (Primary)
- Indications Bladder cancer; Ureteral-neoplasms; Urethral cancer; Urogenital cancer
- Focus Therapeutic Use
- Acronyms ATLAS
- Sponsors Clovis Oncology
- 05 Jun 2018 Trial design presented at the 54th Annual Meeting of the American Society of Clinical Oncology.
- 16 May 2018 According to a Clovis Oncology media release, data will be presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting.
- 14 May 2018 Planned initiation date changed from 1 Mar 2018 to 1 May 2018.